Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dow B. Hickam, Inc.

Executive Summary

$10 mil. annual sales pharmaceutical marketer in Sugar Land, Texas is "searching for new products we can leverage through our existing manufacturing and marketing capabilities." the firm says in its 1985 annual report. The company is essentially a one-product company, based on sales of Granulex, an aerosol medication for bed sores. A handwash/surgical scrub line, Neotec, purchased in 1983 is being delayed by a new drug argument, with FDA. The company says it is looking for already marketed products or "products the developers choose not to market for themselves." In 1985, the company had profits of $1.5 mil. and working capital of $7.4 mil
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS009883

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel